Substantially attenuated hemodynamic responses to Escherichia coli- derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 103-110

  Yang, Renhui ^a   Bunting, Stuart ^a   Ko, Annie ^a   Keyt, Bruce A ^a   Modi, Nishit B ^a   Zioncheck, Thomas F ^a   Ferrara, Napoleone ^a   Jin, Hongkui ^a,b  

^a Qenentech Inc   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTERIAL PRESSURE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPOTENSION; INFUSION; ISCHEMIA; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANIMALS; CHO CELLS; CRICETINAE; ENDOTHELIAL GROWTH FACTORS; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LYMPHOKINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031936486     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE and Unger EF (1994) Angiogenic-induced endothelial enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189.
2. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF and Isner JM (1995) Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 21:314-325.
3. Claffey KP, Senger DR and Spiegelman BM (1995) Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Biochim Biophys Acta 1246:1-9.
4. Conn G, Bayne M, Soderman L, Kwok PW, Sullivan KA, Palisi TM, Hope DA and Thomas KA (1990) Amino acid and cDNA sequence of a vascular endothelial cell mitogen homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632.
5. Connolly DT, Heuvelman D, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegal NR, Leimgfuber R and Feder J (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478.
6. DeGuzman GG, Keck R and Zioncheck TF (1997) Mechanistic difference in the clearance of CHO and E. coli-derived VEGF. Presentation at the American Association of Pharmaceutical Scientists Meeting, April 1997, South San Francisco, CA.
7. Ferrara N and Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
8. Ferrara N, Leung DW, Cachianes G, Winer J and Henzel WJ (1991) Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol 198:391-404.
9. Gibaldi M and Ferner D (1982) Pharmacokinetics, Marcel Dekker, New York.
10. Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM and Symes JF (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63:77-82.
11. Horowitz J, Hariawala M, Sheriff DD, Keyt B and Symes JF (1995) In vivo administration of vascular endothelial growth factor is associated with EDRF-dependent decrease in systemic hypotension in porcine and rabbit. Circulation 92:suppl. I, 630-631.
12. Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814.
13. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J and Connolly DJ (1989) Vascular permeability factor, an endothelial mitogen related to PDGF. Science 246:1309-1312.
14. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H and Ferrara N (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J Biol Chem 271:5638-5646.
15. Kim KJ, Li B, Houck K, Winer J and Ferrara N (1992) The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7:53-64.
16. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
17. Nicosia RF, Nicosia SV and Smith M (1995) Vascular endothelial growth factor, platelet-derived growth factor and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023-1029.
18. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW and Simons M (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med 1:1085-1089.
19. Pepper MS, Ferrara N, Orci L and Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831.
20. Plouet J, Schilling J and Gospodarowicz D (1989) Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 8: 3801-3807.
21. Phillips GD, Stone AM, Jone BD, Schultz JC, Whitehead RA, Knighton DR (1994) Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo 8:961-965.
22. Pu LQ, Sniderman AD, Brassard R, Lachapelle KJ, Graham AM, Lisbona R and Symes JF (1993) Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88:208-215.
23. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS and Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
24. Senger DR, Perruzzi CA, Feder J and Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632.
25. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF and Isner JM (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662-670.
26. Tischer E, Mitchell R, Hartmen T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA (1991) human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954.
27. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N and Adamis AP (1996) VEGF is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate. Arch Ophthalmol 114:964-970.
28. Walter DH, Hink U, Asahara T, Belle EV, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF and Isner JM (1996) The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Lab Invest 74:546-556.
29. Yang R-H, Thomas GR, Bunting S, Ko A, Ferrara N, Keyt B, Ross J and Jin H (1996) Effects of vascular endothelial growth factor on hemodynamic and cardiac performance. J Cardiovasc Pharmacol 27:838-844.